4 Amendments of Daniel CASPARY related to 2011/0401(COD)
Amendment 537 #
Proposal for a regulation
Article 16 – paragraph 1 – subparagraph 1
Article 16 – paragraph 1 – subparagraph 1
All the research and innovation activities carried out under Horizon 2020 shall comply with ethical principles and relevant national, Union and international legislation, including the Charter of Fundamental Rights of the European Union and the European Convention on Human Rights and its Supplementary Protocols. , the Helsinki Declaration, the Convention of the Council of Europe on Human Rights and Biomedicine signed in Oviedo on 4 April 1997 and its Additional Protocols, the European Convention on Human Rights and its Supplementary Protocols, the UN resolution on human cloning of March 2005, the UN Convention on the Rights of the Child, the Universal Declaration on the human genome and human rights adopted by the UNESCO, the UN Biological and Toxin Weapons Convention (BTWC), the International Treaty on Plant Genetic Resources for Food and Agriculture and the relevant World Health Organisation's resolutions. Those carrying out or participating in research projects concerning ethical sensitive issues like for example DNA, analysis on humans, research on persons not able to give informed consent, research linked to the suffering of vertebrate animals etc. shall seek the approval of the relevant national or local ethics committee prior to the start of the activities. An ethical review will also be implemented systematically by the Commission. In specific cases an ethical review may take place during the implementation of a project. On a yearly basis, the Commission shall inform the European Parliament about their activities in this area, and in addition to this, it shall provide the European Parliament and the Council, with information upon request. During the implementation of this programme, scientific advances and national and international provisions shall be regularly monitored by the Commission so as to take account of any developments.
Amendment 1142 #
Proposal for a regulation
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c a (new)
Annex 1 – Part 2 – point 1 – point 1.4 – point 1.4.3 – point c a (new)
(c a) Developing the societal dimension of biotechnology. Focusing on governance of biotechnology for societal benefits including ethical limits.
Amendment 1356 #
Proposal for a regulation
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Annex 1 – Part 3 – point 1 – point 1.3 – paragraph 5
Specific activities shall include: understanding the determinants of health (including environmental and climate related factors), improving health promotion and disease prevention; understanding disease and improving diagnosis; developing effective screening programmes and improving the assessment of disease susceptibility; improving surveillance and preparedness; developing better preventive vaccines; using in-silico medicine for improving disease management and prediction; treating disease; transferring knowledge to clinical practice and scalable innovation actions; better use of health data; active ageing, independent and assisted living; improving palliative medicine, individual empowerment for self-management of health; promotion of integrated care; improving scientific tools and methods to support policy making and regulatory needs; and optimising the efficiency and effectiveness of healthcare systems and reducing inequalities by evidence based decision making and dissemination of best practice, and innovative technologies and approaches.
Amendment 1714 #
Proposal for a regulation
Annex 1 – Part 3 – point 6.3 – point 6.3.2 – paragraph 1 a (new)
Annex 1 – Part 3 – point 6.3 – point 6.3.2 – paragraph 1 a (new)